Literature DB >> 16314214

Ocular allergy: diagnosis and treatment.

Salim Butrus1, Rosaliz Portela.   

Abstract

Ocular allergy is a common hypersensitivity disorder that affects 15%-20% of the population in developed nations. This disorder can be divided into several categories: seasonal and perennial allergic conjunctivitis, atopic keratoconjunctivitis, vernal keratoconjunctivitis, and drug-induced allergic conjunctivitis. Giant papillary conjunctivitis often is included among these classifications of allergy; however, it is not a true allergy, but rather the result of a chronic mechanical irritation. This article reviews these subtypes of ocular allergy, with particular emphasis on the pathophysiology, diagnosis, and treatment of seasonal and perennial allergic conjunctivitis. These are the most common varieties, representing more than 95% of the ocular allergy cases in the United States.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314214     DOI: 10.1016/j.ohc.2005.07.007

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  23 in total

Review 1.  Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.

Authors:  Gyan P Mishra; Viral Tamboli; Jwala Jwala; Ashim K Mitra
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2011-01

2.  Age-dependent changes in peripheral blood dendritic cell subsets in normal children and children with specific polysaccharide antibody deficiency (SPAD).

Authors:  Harumi Jyonouchi; Chongwei Cui; Lee Geng; Zhiwei Yin; Patricia Fitzgerald-Bocarsly
Journal:  Eur J Pediatr       Date:  2010-05-15       Impact factor: 3.183

Review 3.  Emerging Therapeutics for Ocular Surface Disease.

Authors:  Leonard Bielory; Dovid Schoenberg
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-28       Impact factor: 4.806

Review 4.  Allergic conjunctivitis and the impact of allergic rhinitis.

Authors:  Leonard Bielory
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

Review 5.  Antihistamines in ocular allergy: are they all created equal?

Authors:  Mark B Abelson; James T McLaughlin; Paul J Gomes
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

Review 6.  Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management.

Authors:  Stacey Ackerman; Lisa M Smith; Paulo J Gomes
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

Review 7.  Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.

Authors:  Leonard Bielory; C H Katelaris; Susan Lightman; Robert M Naclerio
Journal:  MedGenMed       Date:  2007-08-15

8.  Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study.

Authors:  Harumi Jyonouchi; Lee Geng; Deanna L Streck; Gokce A Toruner
Journal:  J Neuroinflammation       Date:  2012-01-07       Impact factor: 8.322

9.  BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells.

Authors:  Jin-Zhong Zhang; Megan E Cavet; Karl R VanderMeid; Mercedes Salvador-Silva; Francisco J López; Keith W Ward
Journal:  Mol Vis       Date:  2009-12-08       Impact factor: 2.367

Review 10.  Allergic conjunctivitis: a comprehensive review of the literature.

Authors:  Mario La Rosa; Elena Lionetti; Michele Reibaldi; Andrea Russo; Antonio Longo; Salvatore Leonardi; Stefania Tomarchio; Teresio Avitabile; Alfredo Reibaldi
Journal:  Ital J Pediatr       Date:  2013-03-14       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.